May 13, 2020
Arbor Pharmaceuticals Announces FDA Filing Acceptance of New Drug Application (NDA) for AR19, an Investigational ADHD Prescription Stimulant Treatment Specifically Designed to Resist Physical Manipulation for Nonmedical Misuse or Abuse
May 12, 2020
Narcolepsy Market Analysis 2016-2024: Pipeline, Epidemiology, Competitive Analysis, Drug Sales and Shares
Mar 27, 2020
Luye Pharma Continues to Deliver Strong Growth in 2019
Mar 17, 2020
Quillivant XR®, QuilliChew ER® and Dyanavel® XR are 100% Made in the U.S.A. and Remain Consistently Supplied During COVID-19 Pandemic
Dec 26, 2019
Luye Pharma Submits New Drug Application in the U.S. for Its Antidepressant Drug LY03005
Nov 07, 2019
Tris Pharma to Present Two Posters for Amphetamine Extended-Release Tablet at the 2019 Neuroscience Education Institute (NEI) Congress
Sep 26, 2019
DURECT to Present at the 2019 Cantor Fitzgerald Global Health Care Conference
Sep 04, 2019
DURECT to Present at the 21st Annual Rodman and Renshaw Global Investment Conference Sponsored by H.C. Wainwright
Sep 04, 2019
Tris Pharma Strengthens Its Branded Commercial Leadership Team
Aug 29, 2019
Luye Pharma First Half of 2019 Results: Strong Revenue Growth and Substantial Development of R&D Product Pipelines
Jul 25, 2019
DURECT Corporation to Announce Second Quarter 2019 Financial Results on August 1
May 30, 2019
Luye Pharma's Rykindo® NDA Filing Accepted by the U.S. FDA
May 16, 2019
Lannett Begins Marketing Generic Adderall®
Mar 27, 2019
ANI Pharmaceuticals Announces Two Generic Product Launches
Jan 29, 2019
Cognitive and Memory Enhancer Drugs Market to Garner $6.59 Bn, Globally, by 2023 at 8.6% CAGR, Says AMR
Jan 17, 2019
Tris Pharma to Present Three Posters Covering Data on Dyanavel® XR and Tris' LiquiXR® Technology at the 2019 APSARD Annual Meeting
Dec 30, 2018
Luye Pharma Announces Innovative Drug - Risperidone Extended Release Microspheres for Injection has Reached Final Stage of NDA Process
Nov 12, 2018
Tris Pharma Presents Clinical Data for DYANAVEL® XR (amphetamine) at the 2018 Neuroscience Education Institute (NEI) Congress
Oct 16, 2018
ANI Announces Launch of Authorized Generic of Brethine®
Sep 25, 2018
Tris Pharma Expands ADHD Portfolio with Acquisition of NextWave Pharmaceuticals